Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / MOLN - Molecular Partners says data from projected therapeutically active doses of MP0533 from Phase 1/2a trial to be presented in H1

MOLN - Molecular Partners says data from projected therapeutically active doses of MP0533 from Phase 1/2a trial to be presented in H1

Molecular Partners AG

2024-01-08 11:34:43 ET

More on Molecular Partners

For further details see:

Molecular Partners says data from projected therapeutically active doses of MP0533 from Phase 1/2a trial to be presented in H1
Stock Information
Company Name: Molecular Partners AG
Stock Symbol: MOLN
Market: NASDAQ
Website: molecularpartners.com
Menu
MOLN MOLN Quote MOLN Short MOLN News MOLN Articles MOLN Message Board
Get MOLN Alerts

News, Short Squeeze, Breakout and More Instantly...